Cardiovascular Disease in Malaysia: The Harsh Reality and a Way Forward
Novartis Malaysia
Reimagining healthcare: Making evidence-led decisions to offer value-based care for patients.
Early Interventions Can Prevent Premature Deaths
A panel of experts — gathered to launch IQVIA Malaysia's white paper, Heart Matters: The Rising Burden of Cardiovascular Disease in Malaysia and Potential Touchpoints for Interventions — reveals alarming statistics, highlighting the escalating incidence of Cardiovascular Diseases (CVDs) in Malaysia.?
Heart disease is the leading cause of death in the country, accounting for nearly 20% of all mortalities. It is also a significant economic burden — RM3.9 billion is spent to treat CVD annually.
“Underestimating the importance of early detection of high cholesterol increases the likelihood of coronary artery disease and heart attacks in the country.”
- Dato' Sri Dr Azhari Rosman,?Senior Consultant Cardiologist, Institut Jantung Negara
This report underscores that nobody is immune to CVDs. Alarmingly, Malaysians afflicted by CVDs are eight years younger than the global average, compelling an urgent call for interventions and risk management.
Heart Matters: The rising burden of cardiovascular disease in Malaysia and potential touchpoint for interventions
A healthier heartbeat for Malaysia requires a united front. Evidence from IQVIA's white paper shows that cardiovascular health is not a solitary battle — it's a public health issue demanding unified action.
Awareness campaigns, robust primary healthcare services, and tailored policy interventions are necessary. But individual change — embracing healthier lifestyles and improving health-seeking behaviors — is also an important component.
Our shared goal? Improving and extending the lives of 32 million Malaysians.
Media coverage highlighting the need to stem cardiovascular diseases in Malaysia: